In NSCLC, no correlation was found between KRT80 expression in cancer tissues and patients' clinicopathologic factors, including sex, age, smoking history, pathology type, lymph node status, T stage, and AJCC stage. This evidence concerns the gene KRT80 and non-small cell lung carcinoma.